EcoDrugPlus

60s Ribosomal Protein L26

Ensembl ID : ENSOKIG00005025221
Gene Symbol: LOC109878609
3 Cross references
472 Possible Orthologues:

60s Ribosomal Protein L27-Like

Ensembl ID : ENSOKIG00005005343
Gene Symbol: LOC109898708
3 Cross references
361 Possible Orthologues:

60s Ribosomal Protein L28-Like

Ensembl ID : ENSOKIG00005046083
Gene Symbol: LOC109903762
3 Cross references
279 Possible Orthologues:

60s Ribosomal Protein L3-Like

Ensembl ID : ENSOKIG00005002430
Gene Symbol: LOC109897399
3 Cross references
332 Possible Orthologues:

60s Ribosomal Protein L30

Ensembl ID : ENSOKIG00005019229
Gene Symbol: LOC109880494
3 Cross references
409 Possible Orthologues:

60s Ribosomal Protein L31

Ensembl ID : ENSOKIG00005017816
Gene Symbol: LOC109868611
3 Cross references
635 Possible Orthologues:

60s Ribosomal Protein L31-Like

Ensembl ID : ENSOKIG00005032484
Gene Symbol: LOC109877542
2 Cross references
633 Possible Orthologues:

60s Ribosomal Protein L31-Like

Ensembl ID : ENSOKIG00005046761
Gene Symbol: LOC109877542
2 Cross references
633 Possible Orthologues:

60s Ribosomal Protein L37

Ensembl ID : ENSOKIG00005021045
Gene Symbol: LOC109882918
2 Cross references
374 Possible Orthologues:

60s Ribosomal Protein L4-A-Like

Ensembl ID : ENSOKIG00005019951
Gene Symbol: LOC109883543
3 Cross references
339 Possible Orthologues:

60s Ribosomal Protein L8

Ensembl ID : ENSOKIG00005043165
Gene Symbol: LOC109871043
3 Cross references
270 Possible Orthologues:

60s Ribosomal Protein L8-Like

Ensembl ID : ENSOKIG00005001480
Gene Symbol: LOC109870630
3 Cross references
270 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).